Pall® Freeze & Go Solutions Protected by RoSS® Technology

Some combinations are so strong it's simply genius. But when you combine Pall's end-to-end support and class-leading Allegro™ biocontainers with RoSS technology - that's cryogenius.

 

Discover a new one-stop solution for the frozen storage and transport of your drug substance that’s safe, protected, supported and tailored to your process. 

 

See a work of cryogenius!

 

You will learn: 

  • How Freeze & Go Solutions can minimize product loss between bulk filling and final filling production steps
  • The cost and product quality benefits of controlled freezing in single-use biocontainers
  • How comprehensive extractables and leachables and transport validation packages contribute to a one-stop solution

Speaker

Claire Jarmey-Swan

Global Product Manager, Pall Corporation

Biography

David Rigterink

 

Freeze/Transport & Thaw Platforms Specialist, Pall Corporation

Johannes Kirchmair

 

Co-founder and CEO, Single Use Support GmbH

Patrick Evrard

 

 Senior Principal Engineer, Pall Corporation

Peter Black

 

R&D Engineer II, Pall Corporation

Book Your Virtual Freeze & Go Seminar Today!

 

 

Discover more by booking an in-depth seminar customized to your needs including a virtual facility tour.​ Join our experts and learn more how Pall Freeze & Go Solutions protect against leakages and product loss. 

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
April 2022
Getting Ready for SUT X-Ray Irradiation

Biotech | Pall Corporation webinar series

Why the introduction of X-ray sterilization technology is a critical change for single-use industry, and how gamma and X-ray irradiation compare

 

The market demand for gamma irradiation, the current primary method for the sterilization in SUT, will soon significantly exceed supply, creating an urgent need for alternatives.

 

Join Christelle Marcoux from GSK Vaccines (BioPhorum workstream member on alternatives to gamma sterilization) and James Hathcock, PhD of Pall Corporation (Bio-Process Systems Alliance X-Ray Committee Co-Chair) as they discuss the introduction of X-ray sterilization technology.

 

You will learn more about:

 

  • Why this is a critical change for industry and the responsibilities of each stakeholder
  • Key questions to address for biomanufacturers
  • How gamma and X-ray irradiation compare
  • What testing has been completed and key milestones for readiness for industry
  • An example of how to qualify a SUS sterilized with X-ray irradiation
Watch